Special Issue "Role of the Immune System in Neurodegenerative Diseases: A Friend or an Enemy"

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Therapeutic Vaccines and Antibody Therapeutics".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 144

Special Issue Editor

Jackson Laboratory, Bar Harbor, ME, USA
Interests: Alzheimer's disease; multiple sclerosis; innate immunity; microglia; monocyte; modulation of innate immune response; neurodegenerative diseases

Special Issue Information

Dear Colleagues, 

Neurodegenerative disease is a term referring to a broad spectrum of diseases such as Alzheimer’s, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson’s and more. The immune system is deeply involved in the progression of such diseases, and modulating the activation of the latter can have a beneficial impact on these pathologies. On the other side, modulating the immune system can also have a detrimental role. The ambiguous role of the immune system is fascinating and could be the key for future treatments.

This Topic encourages contributors to explore the biological and clinical aspects of modulating the immune system and the impact on animal models, symptoms, and potential treatment. An understanding of these mechanisms can help in the development of new therapeutic approaches.

This topic welcomes original research papers as well as critiques, opinion papers and review.

Dr. Vincent Pons
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • immune system
  • microglia
  • monocytes
  • vaccines
  • neurodegenerative diseases
  • T-cell
  • stroke
  • vasculature
  • neurons

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop